Richard Peters, M.D., Ph.D.
Chairman
Aprea Therapeutics, Inc. (APRE)Board Member
Aprea Therapeutics, Inc. (APRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Peters, M.D., Ph.D.
Richard Peters, M.D., Ph.D. is recorded as Chairman and Board Member at Aprea Therapeutics, Inc. (APRE). Aprea Therapeutics, Inc. reported in an 8-K filed August 24, 2023 that Richard Peters, M.D., Ph.D. was appointed Chairperson of the Board, effective August 23, 2023.
“Following Mr. Schade's resignation, on August 23, 2023, the Board appointed Richard Peters, M.D., Ph.D., to serve as Chairperson of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-23–present
-
Aprea Therapeutics, Inc. (APRE)
SEC 8-K
Current2020-09-16–present
-
Current
2020-06-26–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aprea Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Oren Gilad CEO
- John Hamill CFO
- Scott M. Coiante CFO
- Greg Korbel COO
- Bernd Seizinger Board Member
- Fouad Namouni, M.D. Board Member
- Gabriela Gruia Board Member
- Gabriela Gruia, M.D. Board Member
- Jean-Pierre Bizzari Board Member
- Marc Duey Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.